Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals
Pattern and Surgical Outcome of Papillary Thyroid Cancer: A Case Series Study at Sohag University Hospitals
Studieoversigt
Status
Detaljeret beskrivelse
Papillary thyroid carcinoma (PTC) is the most common histological subtype of thyroid cancer, representing about 80-85% of cases. This study is a case-series study with both retrospective (June 2023 - June 2026) and prospective (June 2026 - March 2027) components, conducted at the Department of General Surgery, Sohag University Hospitals.
All patients diagnosed with papillary thyroid carcinoma and managed at Sohag University Hospitals during the study period will be included. Data collection includes baseline demographic and clinical features, preoperative laboratory tests (thyroid function tests and serum calcium), neck ultrasonography findings (ACR TI-RADS category, nodule size, and lymph node assessment), fine-needle aspiration cytology (Bethesda System), surgical intervention types (hemithyroidectomy, total thyroidectomy, and neck dissection), final histopathological characteristics (tumor size, multifocality, lymphovascular invasion, extrathyroidal extension, and nodal status), and early postoperative complications (hypocalcemia, recurrent laryngeal nerve palsy, hematoma, seroma, and wound sepsis).
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Ahmed Aboulabed Resident Ahmed Aboulabed Ahmed Mousa, resident
- Telefonnummer: 01114522110
- E-mail: ahmed.aboulabed@yahoo.com
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- All patients diagnosed with papillary thyroid carcinoma and its variants managed at Sohag University Hospitals.
- Confirmation of diagnosis histopathologically.
- Availability of sufficient clinical, radiological, operative, and pathological data for analysis.
Exclusion Criteria:
- Patients diagnosed with other types of thyroid malignancy (e.g., follicular, medullary, or anaplastic carcinoma).
- Patients with a history of previous thyroid surgery before presentation to the study setting.
- Patients with incomplete essential medical records that prevent confirmation of diagnosis or extraction of main study variables.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
patients with papillary thyroid carcinoma
All patients diagnosed with papillary thyroid carcinoma (and its variants) managed at Sohag University Hospitals during the study period (June 2023 to March 2027).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Prevalence of Extrathyroidal Extension in Papillary Thyroid Carcinoma
Tidsramme: 9 months
|
Percentage of participants with histologically confirmed extrathyroidal extension.
|
9 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Early Postoperative Surgical Complications
Tidsramme: 9 months
|
Percentage of participants experiencing early postoperative complications including hypocalcemia, recurrent laryngeal nerve palsy, hematoma, seroma, or wound sepsis.
|
9 months
|
|
Incidence of Multifocal Papillary Thyroid Carcinoma
Tidsramme: 9 months
|
Percentage of participants found to have multifocal tumors on final histopathological examination.
|
9 months
|
|
Rate of Cervical Lymph Node Metastasis
Tidsramme: 9 months
|
Percentage of participants with histopathologically confirmed cervical lymph node metastasis.
|
9 months
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i det endokrine system
- Neoplasmer efter sted
- Neoplasmer
- Neoplasmer efter histologisk type
- Neoplasmer i endokrine kirtler
- Neoplasmer i hoved og hals
- Neoplasmer, kirtel og epitel
- Adenocarcinom
- Karcinom
- Skjoldbruskkirtelsygdomme
- Adenocarcinom, papillært
- Kræft i skjoldbruskkirtlen, papillær
- Thyroidneoplasmer
Andre undersøgelses-id-numre
- Soh-Med-26-7-15MS
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .